Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) Q4 2024 Earnings

LFCR·Reported January 2, 2025·After market close

Lifecore Biomedical, Inc. reported Q4 2024 revenue of $32.6M, missed analyst consensus of $33.2M by $665.0K. Diluted EPS came in at $-0.25, beat the $-0.27 consensus by $0.02.

Revenue
$32.6Mmissed by $665.0K
Consensus: $33.2M
Diluted EPS
$-0.25beat by $0.02
Consensus: $-0.27
SEC

SEC Filings

Earnings release8-K · 0001005286-25-000009
Quarterly report10-Q · 0001005286-25-000012

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Lifecore Biomedical, Inc.'s Q4 2024 earnings report.

Lifecore Biomedical, Inc. (LFCR) reported Q4 2024 earnings on January 2, 2025 after market close.

Lifecore Biomedical, Inc. reported revenue of $32.6M and diluted EPS of $-0.25 for Q4 2024.

Revenue missed the consensus estimate of $33.2M by $665.0K. EPS beat the consensus estimate of $-0.27 by $0.02.

You can read the 8-K earnings release (0001005286-25-000009) and the 10-Q periodic report (0001005286-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.